{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:23:59Z","timestamp":1787394239696,"version":"build-2736575974"},"publisher-location":"New York, NY, USA","reference-count":25,"publisher":"ACM","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"DOI":"10.1145\/3809986.3810058","type":"proceedings-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:29:52Z","timestamp":1787387392000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism of Cucurbitacin B (CuB) Targeting BCL2 for Endometrial Carcinoma: Network Pharmacology and Molecular Dynamics Simulation"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8289-4165","authenticated-orcid":false,"given":"Kun","family":"Wang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6604-9614","authenticated-orcid":false,"given":"Dongqing","family":"Ye","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, Anhui, China"},{"name":"School of Public Health, Anhui University of Science and Technology, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9684-6025","authenticated-orcid":false,"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, Anhui, China"},{"name":"School of Public Health, Anhui University of Science and Technology, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"320","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"e_1_3_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1093\/JSCR\/RJAF987"},{"key":"e_1_3_3_1_2_2","doi-asserted-by":"publisher","unstructured":"McCaslin L Lagies S Mohl A D et al.Unveiling Metabolic Subtypes in Endometrial Cancer Cell Lines: Insights from Metabolomic Analysis Under Standard and Stress Conditions.[J]. International journal of molecular sciences 2025 26(19):9573-9573.DOI:10.3390\/IJMS26199573.","DOI":"10.3390\/IJMS26199573"},{"key":"e_1_3_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2025.1586315"},{"key":"e_1_3_3_1_4_2","doi-asserted-by":"publisher","unstructured":"Sun Y H Wang X Wang X L et al.Evolution of lymphovascular space invasion in early-stage endometrial carcinoma: stratification quantification and clinical implications: a systematic review.[J]. Archives of gynecology and obstetrics 2025 312(1):1-7.DOI:10.1007\/S00404-025-07997-6.","DOI":"10.1007\/S00404-025-07997-6"},{"key":"e_1_3_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.7150\/JCA.104214"},{"key":"e_1_3_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1155\/CROM\/7966703"},{"key":"e_1_3_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.4236\/JBM.2025.1310008"},{"key":"e_1_3_3_1_8_2","doi-asserted-by":"publisher","unstructured":"Sun X Xue J Sun Z et al.Associations between molecular subtypes and high-risk pathological factors in endometrial cancer.[J]. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025 (prepublish):1-11.DOI:10.1007\/S12094-025-04089-4.","DOI":"10.1007\/S12094-025-04089-4"},{"key":"e_1_3_3_1_9_2","doi-asserted-by":"publisher","unstructured":"Wang Y Liu G Qin L et al.The relationship and predictive efficacy of serum lipocalin-2 PDK1 NGALR and lymph node metastasis in postmenopausal endometrial cancer.[J]. Translational cancer research 2025 14(9):5550-5558.DOI:10.21037\/TCR-2024-2239.","DOI":"10.21037\/TCR-2024-2239"},{"key":"e_1_3_3_1_10_2","doi-asserted-by":"publisher","unstructured":"Liu C Ji J Li C. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A\/JAK\/STAT3 Signaling Pathway.[J]. The American journal of Chinese medicine 2024 52(01):11-15.DOI:10.1142\/S0192415X24500125.","DOI":"10.1142\/S0192415X24500125"},{"key":"e_1_3_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/PTR.8146"},{"key":"e_1_3_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.JFF.2024.106051"},{"key":"e_1_3_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLSTRUC.2026.145355"},{"key":"e_1_3_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/S00894-025-06558-7"},{"key":"e_1_3_3_1_15_2","doi-asserted-by":"publisher","unstructured":"Cao S Zhao Y Zhang L et al.Unveiling PIK3CA mutation: a prognostic beacon in endometrial carcinoma and its immune implications.[J]. Translational cancer research 2025 14(10):6469-6482.DOI:10.21037\/TCR-2025-704.","DOI":"10.21037\/TCR-2025-704"},{"key":"e_1_3_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/AOC.70476"},{"key":"e_1_3_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/S12672-025-02422-5"},{"key":"e_1_3_3_1_18_2","doi-asserted-by":"publisher","unstructured":"Yang L Nie Y Guo H. Comprehensive Genomic and Immunohistochemical Profiling to Predict Prognosis and Recurrence in Fertility-Sparing Therapy Based on Progesterone for Endometrial Carcinoma.[J]. Technology in cancer research & treatment 2025 2415330338251349972.DOI:10.1177\/15330338251349972.","DOI":"10.1177\/15330338251349972"},{"key":"e_1_3_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.32592\/ARI.2024.79.4.827"},{"key":"e_1_3_3_1_20_2","doi-asserted-by":"publisher","unstructured":"Guven C D Ahmed J Stephen B et al.IGF-1R Inhibitors in Cancer: A Review of Available Evidence and Future Outlook.[J]. Critical reviews in oncology\/hematology 2025 214104809.DOI:10.1016\/J.CRITREVONC.2025.104809.","DOI":"10.1016\/J.CRITREVONC.2025.104809"},{"key":"e_1_3_3_1_21_2","doi-asserted-by":"publisher","unstructured":"Ding X Zheng Y Liu M et al.MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6\/JAK2\/STAT3 Axis in Pancreatic Cancer.[J]. Cancer medicine 2025 14(17):e71179.DOI:10.1002\/CAM4.71179.","DOI":"10.1002\/CAM4.71179"},{"key":"e_1_3_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202518584"},{"key":"e_1_3_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2025.1576060"},{"key":"e_1_3_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2024.1505071"},{"key":"e_1_3_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/S41420-024-01898-4"}],"event":{"name":"BIC 2026: 2026 6th International Conference on Bioinformatics and Intelligent Computing","location":"Dongguan China","acronym":"BIC 2026"},"container-title":["Proceedings of the 2026 6th International Conference on Bioinformatics and Intelligent Computing"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3809986.3810058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:34:47Z","timestamp":1787391287000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3809986.3810058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":25,"alternative-id":["10.1145\/3809986.3810058","10.1145\/3809986"],"URL":"https:\/\/doi.org\/10.1145\/3809986.3810058","relation":{},"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"2026-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}